Black Friday Deal: $15 OFF Forever on All Plans — Limited Time Only!
TKBIF logo
OTC · TKBIFBiotechnologyUpdated Nov 20, 2026

Takara Bio Inc. P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

N/M

No meaningful positive P/E available.

Share price7.3
÷
Earnings per share-0.5327

Price and EPS in quote currency. Calculation details

Zero or negative earnings do not produce a meaningful conventional P/E.

P/E over time

2021 – 2026
Annual P/ESelected-period average 47.68×
3-year average87.16×2 positive annual observations
5-year average50.24×4 positive annual observations
10-year average47.68×5 positive annual observations
Peer median · TTM10.93×5 peers with positive P/E

Historical P/E ratios

Annual period-end data · 6 observations

TKBIF annual P/E history, newest first
Period endP/EChange
Mar 31, 2026N/MN/M
Mar 31, 202595.72×+21.8%
Mar 31, 202478.60×+503.1%
Mar 31, 202313.03×-4.1%
Mar 31, 202213.60×-63.7%
Mar 31, 202137.44×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How TKBIF compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with TKBIF and provider-selected peers
CompanyP/E ratio
TKBIF logo
TKBIF This stockTakara Bio Inc.
N/M
MPSYF logo
MPSYFMorphoSys AG
N/M
ASPHF logo
ASPHFAscentage Pharma Group International
N/M
IZQVF logo
IZQVFIndivior PLC
7.82×
NHNKF logo
NHNKFNihon Kohden Corporation
20.51×
ARHCF logo
ARHCFAlfresa Holdings Corporation
10.93×
INVVY logo
INVVYIndivior PLC
7.82×
DUTV logo
DUTVDigital Utilities Ventures, Inc.
N/M
BIESF logo
BIESFBiotest AG
48.06×

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does TKBIF’s P/E tell you?

01

Start with its own history

Compare positive annual observations to understand how this company has been priced over time. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 5 positive peer ratios above is 10.93×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take TKBIF into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("TKBIF", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

A conventional P/E is not meaningful when earnings are zero or negative. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 20, 2026; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

TKBIF P/E ratio: common questions

The essentials behind the numbers.

Takara Bio Inc. does not currently have a meaningful positive P/E in the quote data. A zero or negative EPS makes the conventional P/E unsuitable for comparison.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.